Myristoylation-Dependent Palmitoylation of the Receptor Tyrosine Kinase Adaptor FRS2α.
Adaptor Proteins, Signal Transducing
/ chemistry
Cell Line, Tumor
Cysteine
/ chemistry
Golgi Apparatus
/ metabolism
Green Fluorescent Proteins
/ metabolism
HEK293 Cells
Humans
Lipoylation
/ physiology
Membrane Microdomains
/ metabolism
Membrane Proteins
/ chemistry
Mutation
Myristic Acid
/ metabolism
Palmitic Acid
/ metabolism
Spectrometry, Fluorescence
Journal
Biochemistry
ISSN: 1520-4995
Titre abrégé: Biochemistry
Pays: United States
ID NLM: 0370623
Informations de publication
Date de publication:
25 06 2019
25 06 2019
Historique:
pubmed:
12
6
2019
medline:
3
6
2020
entrez:
12
6
2019
Statut:
ppublish
Résumé
An early step in signaling from activated receptor tyrosine kinases (RTKs) is the recruitment of cytosolic adaptor proteins to autophosphorylated tyrosines in the receptor cytoplasmic domains. Fibroblast growth factor receptor substrate 2α (FRS2α) associates via its phosphotyrosine-binding domain (PTB) to FGF receptors (FGFRs). Upon FGFR activation, FRS2α undergoes phosphorylation on multiple tyrosines, triggering recruitment of the adaptor Grb2 and the tyrosine phosphatase Shp2, resulting in stimulation of PI3K/AKT and MAPK signaling pathways. FRS2α also undergoes N-myristoylation, which was shown to be important for its localization to membranes and its ability to stimulate downstream signaling events (Kouhara et al., 1997). Here we show that FRS2α is also palmitoylated in cells and that cysteines 4 and 5 account for the entire modification. We further show that mutation of those two cysteines interferes with FRS2α localization to the plasma membrane (PM), and we quantify this observation using fluorescence fluctuation spectroscopy approaches. Importantly, prevention of myristoylation by introduction of a G2A mutation also abrogates palmitoylation, raising the possibility that signaling defects previously ascribed to the G2A mutant may actually be due to a failure of that mutant to undergo palmitoylation. Our results demonstrate that FRS2α undergoes coupled myristoylation and palmitoylation. Unlike stable cotranslational modifications, such as myristoylation and prenylation, palmitoylation is reversible due to the relative lability of the thioester linkage. Therefore, palmitoylation may provide a mechanism, in addition to phosphorylation, for dynamic regulation of FRS2 and its downstream signaling pathways.
Identifiants
pubmed: 31184863
doi: 10.1021/acs.biochem.9b00299
pmc: PMC6800032
mid: NIHMS1053900
doi:
Substances chimiques
Adaptor Proteins, Signal Transducing
0
FRS2 protein, human
0
Membrane Proteins
0
enhanced green fluorescent protein
0
Myristic Acid
0I3V7S25AW
Green Fluorescent Proteins
147336-22-9
Palmitic Acid
2V16EO95H1
Cysteine
K848JZ4886
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2809-2813Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM064589
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM113079
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM121536
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI083196
Pays : United States
Commentaires et corrections
Type : ErratumIn
Références
Proteomics. 2004 Jun;4(6):1626-32
pubmed: 15174132
J Biol Chem. 2012 Jan 2;287(1):523-30
pubmed: 22081607
Mol Cell Biol. 2000 Feb;20(3):979-89
pubmed: 10629055
Proc Natl Acad Sci U S A. 2014 Apr 15;111(15):5514-9
pubmed: 24706887
J Biol Chem. 2009 Jun 5;284(23):15980-92
pubmed: 19339244
J Biol Chem. 2003 Apr 18;278(16):13803-9
pubmed: 12571252
J Biol Chem. 2001 Oct 26;276(43):39501-4
pubmed: 11527981
Sci Rep. 2016 Jun 16;6:28249
pubmed: 27306108
Science. 2006 Dec 1;314(5804):1458-61
pubmed: 17095657
J Biol Chem. 2018 Apr 27;293(17):6434-6448
pubmed: 29540482
Biophys J. 2010 Aug 4;99(3):979-88
pubmed: 20682277
J Proteome Res. 2018 May 4;17(5):1907-1922
pubmed: 29575903
Appl Spectrosc. 2004 May;58(5):122A-137A
pubmed: 15165323
Cell. 1997 May 30;89(5):693-702
pubmed: 9182757
Bioinformatics. 2006 Apr 1;22(7):894-6
pubmed: 16434441
Expert Opin Ther Targets. 2009 Jun;13(6):689-700
pubmed: 19456272
Biochemistry. 2010 Aug 3;49(30):6305-16
pubmed: 20583817
J Genet Genomics. 2015 Oct 20;42(10):521-529
pubmed: 26554907
J Cell Biol. 2014 Apr 14;205(1):113-26
pubmed: 24711504
Cancer Sci. 2008 Jul;99(7):1319-25
pubmed: 18452557
Nat Methods. 2011 Nov 06;9(1):84-9
pubmed: 22056678
Science. 2010 Jan 1;327(5961):46-50
pubmed: 20044567
Biophys J. 2017 Jul 11;113(1):138-147
pubmed: 28700912
FEBS J. 2008 May;275(9):2055-66
pubmed: 18355321
Anal Biochem. 2015 Jul 1;480:11-20
pubmed: 25862080